Opaleye Management Inc. Q1 2016 Filing
Filed May 16, 2016
Portfolio Value
$158.6M
Holdings
50
Report Date
Q1 2016
Filing Type
13F-HR
All Holdings (50 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | AXGNAXOGEN INC | 2,120,000 | $11.4M | 7.16% | |
| 2 | —ARIAD PHARMACEUTICALS INC | 1,250,000 | $8.0M | 5.04% | |
| 3 | RAREULTRAGENYX PHARMACEUTICAL IN | 110,000 | $7.0M | 4.39% | |
| 4 | FGENEURFIBROGEN INC | 325,000 | $6.9M | 4.36% | |
| 5 | —PROTALIX BIOTHERAPEUTICS INC | 8,200,000 | $6.9M | 4.34% | |
| 6 | —MEDGENICS INC | 1,557,700 | $6.9M | 4.32% | |
| 7 | —ADAMAS PHARMACEUTICALS INC | 320,000 | $6.1M | 3.82% | |
| 8 | CARAEURCARA THERAPEUTICS INC | 855,000 | $5.3M | 3.35% | |
| 9 | SG7SAGE THERAPEUTICS INC | 165,000 | $5.3M | 3.33% | |
| 10 | AMAGAMAG PHARMACEUTICALS INC | 220,000 | $5.1M | 3.25% | |
| 11 | —IMPRIMIS PHARMACEUTICALS INC | 1,250,000 | $5.0M | 3.13% | |
| 12 | —INOTEK PHARMACEUTICALS CORP | 645,000 | $4.8M | 3.01% | |
| 13 | —DEPOMED INC | 325,000 | $4.5M | 2.85% | |
| 14 | AGIOAGIOS PHARMACEUTICALS INC | 105,000 | $4.3M | 2.69% | |
| 15 | —CYTRX CORP | 1,440,000 | $4.1M | 2.60% | |
| 16 | 2L9BLUEPRINT MEDICINES CORP | 220,000 | $4.0M | 2.50% | |
| 17 | GONGERON CORP | 1,325,000 | $3.9M | 2.44% | |
| 18 | —FOAMIX PHARMACEUTICALS LTD | 590,000 | $3.8M | 2.43% | |
| 19 | CDXSCODEXIS INC | 1,178,500 | $3.7M | 2.31% | |
| 20 | TGTXTG THERAPEUTICS INC | 415,000 | $3.5M | 2.23% | |
| 21 | CMRXEURCHIMERIX INC | 675,000 | $3.4M | 2.17% | |
| 22 | —OPHTHOTECH CORP | 80,000 | $3.4M | 2.13% | |
| 23 | —IMMUNOMEDICS INC | 1,325,000 | $3.3M | 2.09% | |
| 24 | XENEXENON PHARMACEUTICALS INC | 400,000 | $2.8M | 1.76% | |
| 25 | AMRNAMARIN CORP PLC | 1,760,000 | $2.7M | 1.70% | |
| 26 | —INTEC PHARMA LTD JERUSALEM | 638,000 | $2.6M | 1.66% | |
| 27 | —NABRIVA THERAPEUTICS AG | 273,800 | $2.5M | 1.55% | |
| 28 | EGRXEAGLE PHARMACEUTICALS INC | 60,000 | $2.4M | 1.53% | |
| 29 | —AFFIMED N V | 610,000 | $2.3M | 1.44% | |
| 30 | —ZOGENIX INC | 240,000 | $2.2M | 1.40% | |
| 31 | —RETROPHIN INC | 150,000 | $2.0M | 1.29% | |
| 32 | SUPNSUPERNUS PHARMACEUTICALS INC | 125,000 | $1.9M | 1.20% | |
| 33 | TREURTRILLIUM THERAPEUTICS INC | 195,000 | $1.8M | 1.14% | |
| 34 | —EDGE THERAPEUTICS INC | 185,000 | $1.7M | 1.07% | |
| 35 | —CYNAPSUS THERAPEUTICS INC | 121,000 | $1.4M | 0.91% | |
| 36 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 175,300 | $1.4M | 0.90% | |
| 37 | —CORIUM INTL INC | 360,000 | $1.4M | 0.88% | |
| 38 | —AURIS MED HLDG AG | 340,000 | $1.2M | 0.78% | |
| 39 | —OHR PHARMACEUTICAL INC | 366,000 | $1.2M | 0.74% | |
| 40 | —XOMA CORP DEL | 1,350,000 | $1.0M | 0.66% | |
| 41 | —TENAX THERAPEUTICS INC | 499,600 | $1.0M | 0.65% | |
| 42 | —ACHAOGEN INC | 255,000 | $704K | 0.44% | |
| 43 | NKTREURNEKTAR THERAPEUTICS | 50,000 | $688K | 0.43% | |
| 44 | —MEDIVATION INC | 14,500 | $667K | 0.42% | |
| 45 | —EVOKE PHARMA | 130,000 | $662K | 0.42% | |
| 46 | —NEURODERM LTD | 38,500 | $544K | 0.34% | |
| 47 | —NIVALIS THERAPEUTICS INC | 100,000 | $417K | 0.26% | |
| 48 | ACRSACLARIS THERAPEUTICS INC | 18,000 | $341K | 0.21% | |
| 49 | —BIOLINERX LTD | 250,000 | $255K | 0.16% | |
| 50 | —CHIASMA INC | 20,000 | $183K | 0.12% |